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Abbreviations {#feb212388-sec-0001}
=============

**CRISPR**, clustered regularly interspaced short palindromic repeats

**DA**, Dark Agouti

**ES cell**, embryonic stem cell

**F344**, Fischer 344

**H&E**, hematoxylin and eosin

**neo**, neomycin

**SD**, Sprague--Dawley

***tk***,*thymidine kinase*

**WT**, wild‐type

**ZFN**, zinc‐finger nucleases

 {#feb212388-sec-0002}

Although rats have been widely used as research animal models, until recently, genetic tools in rats have lagged behind the mouse due to lack of authentic embryonic stem cells. Since 2008, successful isolation of rat embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells) paved the way for rat genome engineering and rat model creation [1](#feb212388-bib-0001){ref-type="ref"}, [2](#feb212388-bib-0002){ref-type="ref"}, [3](#feb212388-bib-0003){ref-type="ref"}, [4](#feb212388-bib-0004){ref-type="ref"}. New tools represented by clustered regularly interspaced short palindromic repeats (CRISPR/Cas9) have offered an alternative to conventional knockout technology (ES cells‐based gene targeting) to quickly generate gene‐modified rats [5](#feb212388-bib-0005){ref-type="ref"}, [6](#feb212388-bib-0006){ref-type="ref"}, [7](#feb212388-bib-0007){ref-type="ref"}, [8](#feb212388-bib-0008){ref-type="ref"}. Yet, it has become clear that conventional homologous recombination‐based gene targeting technology is still the best choice to generate precise gene‐modified models.

In conventional gene targeting or CRISPR‐assisted gene targeting in ES cells, to increase gene targeting efficiency, selection genes are used [9](#feb212388-bib-0009){ref-type="ref"}, [10](#feb212388-bib-0010){ref-type="ref"}. As shown in mice, the selection genes can result in unwanted consequences such as misregulation of adjacent genes or expression attenuation of the gene of interest [11](#feb212388-bib-0011){ref-type="ref"}, [12](#feb212388-bib-0012){ref-type="ref"}, [13](#feb212388-bib-0013){ref-type="ref"}, [14](#feb212388-bib-0014){ref-type="ref"}. Accordingly, several recombinase systems including Cre‐*lox*P, FLP/FRT, and PhiC31 have been developed to solve these issues [15](#feb212388-bib-0015){ref-type="ref"}, [16](#feb212388-bib-0016){ref-type="ref"}, [17](#feb212388-bib-0017){ref-type="ref"}, [18](#feb212388-bib-0018){ref-type="ref"}, [19](#feb212388-bib-0019){ref-type="ref"}, [20](#feb212388-bib-0020){ref-type="ref"}. Among these, researchers combined the Cre‐*lox*P system with testes‐specific promoter tACE and subsequently developed the ACN self‐excision cassette [21](#feb212388-bib-0021){ref-type="ref"}. The tACE promoter initiates transcription of Cre during spermatogenesis, followed by automatic excision of floxed selection gene as well as *Cre*. Since the first application of the ACN strategy in 1999, numerous research groups have used it to generate mouse mutant models. As more and more rat models are being generated, it would be advantageous to apply ACN self‐excision cassette as a rat gene targeting strategy.

In this study, we attempted to demonstrate that genetic reagents used in conventional mouse knockout technology can be used in rats. With an optimized gene targeting procedure, we generated knockout rats for *Leptin* and *Trp53* (*p53*) genes with homologous recombination‐based vectors containing ACN cassette, and proved they were free of selection genes, indicating that the ACN self‐excision cassette works well in rat gene targeting.

Materials and methods {#feb212388-sec-0003}
=====================

Animals {#feb212388-sec-0004}
-------

Male Dark Agouti (DA) rats were purchased from Shanghai Laboratory Animal Research Center (Shanghai, China). Sprague--Dawley (SD) rats were purchased from Charles River Laboratories (Beijing, China). All animal experiments were approved by Laboratory Animal Care and Use Committee of China Agricultural University. All rats used in this study were backcrossed to SD genetic background.

Vector construction {#feb212388-sec-0005}
-------------------

The *Leptin*‐ and *p53*‐targeting vectors were constructed according to previous protocol [22](#feb212388-bib-0022){ref-type="ref"}. The homologous arm were amplified from SD rat genomic DNA by PCR. We introduced Gluc as a reporter to indicate the expression level of *Leptin*, and ACN as a self‐excision cassette to generate selection‐gene‐free heterozygous mutant rats from chimeras [21](#feb212388-bib-0021){ref-type="ref"}.

ES cell lines {#feb212388-sec-0006}
-------------

The SD and F344 ES cells were obtained from Rat Resource and Research Center (SD‐Tg (GFP) 2BalRrrc‐ES1/Rrrc, RRRC\#: 561; F344‐Tg (UBC‐EGFP) F455Rrrc‐ES4011/Rrrc, RRRC\#: 654) [23](#feb212388-bib-0023){ref-type="ref"}, [24](#feb212388-bib-0024){ref-type="ref"}. All ES cells were cultured in 3i/Lif medium, supplemented with 0.5 [m]{.smallcaps} A83‐01 (Tocris, San Diego, CA, USA), 3 m[m]{.smallcaps} CHIR99021 (Selleck Chemicals, Houston, TX, USA), 0.5 m[m]{.smallcaps} PD0325901 (Selleck Chemicals), and 1000 units·mL^−1^ rat Lif (ESGRO, Millipore, Bedford, MA, USA) in N2B27 (Invitrogen, Carlsbad, CA, USA) medium. β2 mouse fibroblasts with 40 Gy Co^60^ g‐ray treated were used as feeders.

Electroporation and screening {#feb212388-sec-0007}
-----------------------------

The targeting vectors containing the *neo/tk* double selection cassette were linearized with *Swa*I. Approximately, 6 μg linearized targeting vectors were electroporated to 2 × 10^6^ ES cells using Lonza Amaxa Nucleofector‐2b program B‐016. Twenty‐four hours after nucleofection, transfected ES cells were selected for resistance to G418 (400 μg·mL^−1^; EMD Chemicals, Inc., San Diego, CA, USA) and FIAU (0.3 μ[m]{.smallcaps}) for 5 days. About 10 days after electroporation, drug‐resistant colonies were picked and propagated for cryopreservation and screening. To screen successful homologous recombination clones, DNA was extracted from each isolated clone and amplified using TaKaRa LA Taq^®^ DNA Polymerase under previously reported protocol [22](#feb212388-bib-0022){ref-type="ref"}. Primers WS1147 and WS1149 were used for PCR screening of *Leptin* gene‐targeted ES cells. Primers LH‐21 and LH‐20 were used for PCR screening of *p53* gene‐targeted ES cells.

Targeted cell karyotyping {#feb212388-sec-0008}
-------------------------

Targeted cell karyotypes were analyzed according to previous reports [23](#feb212388-bib-0023){ref-type="ref"}, [24](#feb212388-bib-0024){ref-type="ref"}. The chromosome number was counted by [leica cytovision]{.smallcaps} software (Leica Camera AG, Wetzlar, Germany). The karyotyping analysis was performed at passage of 6--10.

Generation of chimeras and breeding {#feb212388-sec-0009}
-----------------------------------

Chimeras were generated by blastocyst injections as previously reported [23](#feb212388-bib-0023){ref-type="ref"}, [24](#feb212388-bib-0024){ref-type="ref"}. Heterozygous clones with correct chromosome number were injected into DA × SD hybrid blastocysts. Chimeric animals were identified from offspring by coat color chimerism. Male chimeric animals derived from successfully targeted cell lines were bred to SD mates to produce gene‐targeting animals.

Genotyping and Southern blot analysis {#feb212388-sec-0010}
-------------------------------------

DNA was extracted from tail biopsies of chimeric males and their progenies. Fragments were amplified by using GoTaq^®^ Flexi DNA Polymerase (Promega, Madison, AL, USA). Approximately, 200 ng genomic DNA was used for PCR amplification for 32 cycles in a 12.5‐μL reaction mixture. PCR products with different size were used to distinguish wild‐type, ACN removal, and ACN‐containing mutant rats. Genomic DNA (10 μg) was digested with appropriate enzymes overnight for Southern blot analysis. Probes were prepared by PCR amplification using PCR DIG Probe Synthesis Kit (Roche, Basel, Switzerland). Southern blotting was performed as described previously.

Western blot analysis {#feb212388-sec-0011}
---------------------

The total tissue proteins were extracted from white adipose tissue of *Leptin* mutant rats and their wild‐type littermates with RIPA lysis buffer (Beyotime, Shanghai, China; P0013B). One hundred micrograms of protein was denatured at 95--100 °C for 10 min in sample buffer, then separated by 10% SDS/PAGE and transferred onto polyvinylidene fluoride membrane (GE Healthcare, Little Chalfont, Buckinghamshire, UK). The anti‐*Leptin* primary antibody (Abcam, Cambridge, MA, USA; ab3583) was used at 1 : 4000 dilution and anti‐tubulin primary antibody (Beyotime; AT819) was used at 1 : 10 000. The anti‐rabbit secondary antibody (Beyotime; A0208) was used at the dilution of 1 : 10 000. SuperSignal West‐Dura Extended Duration Substrate kit (Thermo Fisher Scientific, Waltham, MA, USA; \#34075) was used to develop the signal.

Body weight and random blood glucose {#feb212388-sec-0012}
------------------------------------

*Leptin* mutant rats and their control littermates were weighed every month from 1 to 8 months old. Blood was collected by tail vein puncture and blood glucose was analyzed by Roche Accu‐CHEK Performa glucometer (Roche). Random blood glucose was measured at 9:00 a.m.

Histological analysis {#feb212388-sec-0013}
---------------------

Rats were euthanized, and the liver, pancreas, and abdominal adipose tissue were fixed in 4% formaldehyde and mounted in paraffin blocks. The sections were stained with hematoxylin and eosin (H&E).

Results {#feb212388-sec-0014}
=======

Generation of *Leptin* knockout rats using vectors containing ACN cassette {#feb212388-sec-0015}
--------------------------------------------------------------------------

The introduction of the ACN self‐excision cassette into the gene targeting strategy significantly promotes the generation of selection‐gene‐free mouse models [21](#feb212388-bib-0021){ref-type="ref"}, [22](#feb212388-bib-0022){ref-type="ref"}, [25](#feb212388-bib-0025){ref-type="ref"}, [26](#feb212388-bib-0026){ref-type="ref"}. To test whether the same approach works in rats, we designed a *Leptin* targeting strategy by knocking IRES‐Gluc and ACN self‐excision cassette into the second exon (Fig. [1](#feb212388-fig-0001){ref-type="fig"}A). We next electrotransfected linearized targeting vectors into SD rat ES cells (male). Previously published reports have suggested that rat ES cells are sensitive to drug selection, and *thymidine kinase* (*tk*) could not be used as negative selection gene for rat gene targeting [27](#feb212388-bib-0027){ref-type="ref"}, [28](#feb212388-bib-0028){ref-type="ref"}. However, we performed both G418‐positive and 1‐(2‐deoxy‐2‐fluoro‐beta‐[d‐]{.smallcaps}arabinofuranosyl)‐5‐iodouracil (FIAU)‐negative drug selection against *neomycin* (*neo*) and *tk* at similar concentration as used for mouse ES cells for five successive days to enrich *Leptin* gene‐targeted rat ES cells. The colonies passed through the drug selection were picked and expanded for further analysis. To identify gene‐targeted clones, we used long‐range PCR to amplify regions flanking the *Leptin*‐modified region, and 3 of 18 (17%) colonies were confirmed to have undergone the desired gene targeting events (Fig. [1](#feb212388-fig-0001){ref-type="fig"}B).

![Gene targeting strategy for *Leptin* via homologous recombination. (A) Genomic structure of wild‐type *Leptin* allele (top), the *Leptin* targeting vector (the second line), targeted allele in rat ES cells (the third line), and targeted allele in mutant rats (bottom). Different colors represented different elements. The 5′ and 3′ probes used for Southern blot analysis were shown as purple lines. *Kpn*I was used to digest genomic DNA from *Leptin* mutant rats and their littermates. The drug‐resistant genes *neo* and *HSVtk* were used for positive/negative selection in rat ES cells. The cassette containing tACE, *Cre*, polymerase II promoter, and *neo* flanked with *lox*P sites was named as ACN [21](#feb212388-bib-0021){ref-type="ref"}. Primers WS1147 and WS1149 are used to identify gene targeting event. Primers LH‐28, LH‐29, and LH‐30 are used to identify germline transmission. Primers LH‐29 and LH‐35 are used to test if ACN is removed. (B) PCR screening strategy of gene‐targeted ES cell clones. We amplified DNA of 12 isolated colonies and obtained three successfully targeted clones (No. 17‐3 17‐4 and 17‐17) with a product size of 2.9 kb. PCR with H~2~O template was used as a blank control. IRES, internal ribosome entry site; Gluc, Gaussia luciferase; tACE, the murine angiotensin‐converting enzyme; *tk*, herpes simplex virus *thymidine kinase* gene.](FEB2-590-3416-g001){#feb212388-fig-0001}

Next, *Leptin* gene‐targeted ES cells with correct karyotypes were injected into F1 blastocysts from Dark Agouti male crossed to SD female for generation of chimeras. Four males and three females were chimeric (identified by coat color) in a total of 22 pups obtained (Table [1](#feb212388-tbl-0001){ref-type="table-wrap"}). The male chimeras were mated to wild‐type SD female rats for offspring production, and 2 of 240 pups were genotyped as heterozygous, indicating the successful generation of *Leptin* knockout rats.

###### 

Generation of chimeras via blastocyst injection with *Leptin* and *p53* homologous recombination cell lines and germline transmission

             Donor blastocyst   Recipient   Transferred embryos   Total pups   Coat color chimera   Offspring   No. of germline transmission
  ---------- ------------------ ----------- --------------------- ------------ -------------------- ----------- ------------------------------
  *Leptin*   DA × SD            SD          193                   22           4M; 3F               240         2
  *p53*      DA × SD            SD          169                   42           6M; 5F               210         2

M, male; F, female.

John Wiley & Sons, Ltd

Identification of self‐excision of ACN cassette in mutant offspring rats {#feb212388-sec-0016}
------------------------------------------------------------------------

To confirm the removal of the ACN cassette in mutant offspring rats, we designed a PCR strategy that produced a specific amplicon for wild‐type, gene‐targeted, or ACN‐removed alleles (Fig. [2](#feb212388-fig-0002){ref-type="fig"}A). The two *Leptin* heterozygous animals showed a 529 bp specific band indicating successful removal of ACN cassette (Fig. [2](#feb212388-fig-0002){ref-type="fig"}B). We further bred the heterozygous animals to produce homozygous *Leptin* knockout mutants. Southern blot analysis of genomic DNA extracted from offspring tails showed that all the mutants had the neo cassette removed (Fig. [2](#feb212388-fig-0002){ref-type="fig"}C).

![Removal of ACN cassette in *Leptin* knockout rats. (A) Structure of the wild‐type *Leptin* allele (top), the targeted allele in ES cells and chimera (middle), and the targeted allele in mutant rats (bottom). (B) PCR verification of ACN removal. DNA was extracted from wild‐type ES cells (ES), recombinant ES cell lines (17‐3 and 17‐4), tail biopsies of male chimera \#3, and F1 progenies obtained from chimera \#3 germline transmission. Product size: wild‐type, 251 bp; ACN‐removed allele: 529 bp; ACN‐containing allele: 381 bp. PCR with H~2~O template was used as a blank control. (C) Southern blot analysis of *Leptin* mutant rats using 5′ and 3′ probes. DNA extracted from a cross of heterozygous rats was digested with *Kpn*I. The wild‐type band is 8.9 kb and *Leptin* mutant bands with 5′ and 3′ probes are 6 and 4.5 kb, respectively.](FEB2-590-3416-g002){#feb212388-fig-0002}

Taken together, the strategy of automatic removal of a selection gene using the ACN cassette worked efficiently in rats.

Characterization of *Leptin* mutant rats {#feb212388-sec-0017}
----------------------------------------

Leptin is a hormone secreted by adipocyte that regulates energy metabolism. To examine *Leptin* function in rats, we analyzed the phenotype of our *Leptin* mutant rats, and found these *Leptin* ^−/−^ mutant rats were overtly obese (Fig. [3](#feb212388-fig-0003){ref-type="fig"}A). The western blot analysis of total protein also confirmed the loss of *Leptin* in white adipose tissue of *Leptin* mutant rats (Fig. [3](#feb212388-fig-0003){ref-type="fig"}B). Body weight of *Leptin* ^−/−^ rats and their littermates was measured beginning at 1 month of age. In comparison with control littermates, both male and female *Leptin* ^−/−^ rats showed significantly heavier body mass over time (Fig. [3](#feb212388-fig-0003){ref-type="fig"}C).

![*Leptin* mutant rats are obese. (A) A representative *Leptin* mutant rat is overtly obese compared to its wild‐type (WT) littermate at 8 months old. (B) Western blot analysis for Leptin protein expression of white adipose tissues in WT and *Leptin* mutant rats. No Leptin protein was detected in mutant rats. Tubulin was used as a loading control. (C) Body weight was measured over 8 months for male control littermates (*n* = 3), male *Leptin* mutant rats (*n* = 2), female control littermate (*n* = 4), and female *Leptin* mutant rats (*n* = 4). Both male and female *Leptin* ^−/−^ rats demonstrated significantly heavier body mass than controls. (D) Hematoxylin and eosin (H&E) staining of the liver, pancreas, and adipose tissue revealed pathological changes in *Leptin* mutant rats. Scale bar = 200 μm. Data were represented as mean ± SEM, Student\'s *t*‐tests were performed using [graphpad prism]{.smallcaps} software (GraphPad Software, Inc. La Jolla, CA, USA). \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001 versus control littermate rats.](FEB2-590-3416-g003){#feb212388-fig-0003}

We next investigated pathological changes of pancreas, liver, adipose tissue, and kidney. In comparison with their control littermates, the *Leptin* ^−/−^ rats showed obviously larger adipocytes and severe hepatic steatosis, and the pancreatic islets of the *Leptin* ^−/−^ rats displayed severe hypertrophy and vacuolation (Fig. [3](#feb212388-fig-0003){ref-type="fig"}D).

In conclusion, homozygous *Leptin* gene knockout rats exhibited a significant obesity phenotype, consistent with previous reports for mutant *Leptin* and *Leptin* receptor rats generated by zinc‐finger nucleases (ZFN) and CRISPR/Cas9 technologies [29](#feb212388-bib-0029){ref-type="ref"}, [30](#feb212388-bib-0030){ref-type="ref"}, [31](#feb212388-bib-0031){ref-type="ref"}.

Successful application of ACN self‐excision cassette in *p53* gene‐targeting rats {#feb212388-sec-0018}
---------------------------------------------------------------------------------

To verify the ACN cassette also works in other gene loci, we designed the *p53* gene‐targeting vector using a similar strategy to *Leptin* (Fig. [4](#feb212388-fig-0004){ref-type="fig"}A). The linearized *p53* gene‐targeting vectors were introduced into F344 ES cells using nucleofection. After G418/FIAU drug selection, we identified 5 of 20 colonies with correct gene targeting events by long‐range PCR (Fig. [4](#feb212388-fig-0004){ref-type="fig"}B). Positive gene‐targeted ES cells with normal karyotypes were then used for chimeric animal generation. We obtained 42 pups in total and 11 (6 male and 5 female) were identified as chimeric animals by coat color (Table [1](#feb212388-tbl-0001){ref-type="table-wrap"}). All six male chimeras were bred with wild‐type SD females, and two were capable of germline transmission based on PCR analysis of their offspring.

![Gene targeting strategy for *p53*. (A) Genomic structure of the wild‐type *p53* allele, *p53* targeting vector, targeted allele in ES cells, and targeted allele in mutant rats. The 5′ and 3′ probes used for Southern blot analysis were shown as red lines, and the restriction enzyme *Bsr*GI and *Eco*RI were used for digestion. *Neo* and *HSVtk* were used for positive/negative selection in rat ES cells. Primers LH‐20 and LH‐21 are used for screening positive targeted ES clones. Primers LH‐40, LH‐41, and LH‐42 are used to identify germline transmission. Primers LH‐40 and LH‐35 are used to test if ACN cassette is removed. (B) PCR analysis of the positive targeted ES cell clones. The positive targeted ES cell clones were 27‐1, 27‐7, 27‐11, 27‐13, and 27‐17 with the product size of 2.7 kb. PCR with H~2~O template was used as a blank control. (C) PCR analysis of ACN removal. DNA was extracted from wild‐type ES cells (ES), recombinant ES cell line (27‐13), tail biopsies of male chimera \#1, and F1 progenies produced from chimera \#1. Product size: wild‐type, 317 bp; ACN‐removed allele: 383 bp; ACN‐containing allele: 509 bp. (D) Southern blot analysis of *p53* mutant rats using 5′ and 3′ probes. DNA extracted from offspring tails obtained by crossing heterozygous rats was digested with *Bsr*GI and *Eco*RI. The wild‐type band is 14 kb and *p53* mutant band is 7.3 kb with 5′ probe. The wild‐type band is 11 kb and *p53* mutant band is 5.4 kb with 3′ probe.](FEB2-590-3416-g004){#feb212388-fig-0004}

To confirm the removal of selection gene in F1 heterozygous progeny, we designed a PCR strategy to distinguish wild‐type, gene‐targeted, or ACN‐removed alleles. The two *p53* heterozygous animals showed a 383 bp band specific for the ACN‐removed allele demonstrating successful removal of ACN cassette (Fig. [4](#feb212388-fig-0004){ref-type="fig"}C). We also used Southern blot to analyze DNA extracted from offspring tails obtained by crossing heterozygous rats, and the result showed that the neo cassette was removed in all mutant alleles (Fig. [4](#feb212388-fig-0004){ref-type="fig"}D).

In summary, we generated *p53* gene knockout rats without selection genes which suggested the ACN self‐excision cassette has broad application in rat gene targeting.

Discussion {#feb212388-sec-0019}
==========

Although germline competent rat ES cells were derived since 2008, few homologous recombination‐mediated gene knockout/knockin rats have been reported, and none of them mentioned the elimination of selection genes [1](#feb212388-bib-0001){ref-type="ref"}, [2](#feb212388-bib-0002){ref-type="ref"}, [27](#feb212388-bib-0027){ref-type="ref"}, [32](#feb212388-bib-0032){ref-type="ref"}, [33](#feb212388-bib-0033){ref-type="ref"}, [34](#feb212388-bib-0034){ref-type="ref"}. Rats are more superior animal models than mice in many areas of biomedical research, but applying genetic modification technologies in the rat is still in its infancy. Therefore, successfully extending mouse‐derived sophisticated gene‐targeting strategies to rats has great significance. Here, we have demonstrated the feasibility of ACN self‐excision in rat gene targeting strategy, and successfully generated *Leptin* and *p53* gene knockout rats containing no selection genes. In addition, the Cre expression in the ACN in rat was very accurate and specific only during the spermatogenesis, and the efficiency of excision *in vivo* can reach 100%. Our study will greatly increase the possibility of successful application in other species.

In our study, the frequency of both *Leptin* and *p53* gene targeting via homologous recombination was \~ 20% with SD and F344 ES cells, in comparison with previously reported typical efficiencies of 0.6--4.4% [27](#feb212388-bib-0027){ref-type="ref"}, [34](#feb212388-bib-0034){ref-type="ref"}. Although germline‐competent rat ES cells have been derived from various strains [1](#feb212388-bib-0001){ref-type="ref"}, [2](#feb212388-bib-0002){ref-type="ref"}, [23](#feb212388-bib-0023){ref-type="ref"}, [35](#feb212388-bib-0035){ref-type="ref"}, the knockout rats generated via homologous recombination have only been achieved in DA rats [27](#feb212388-bib-0027){ref-type="ref"}, [32](#feb212388-bib-0032){ref-type="ref"}, [34](#feb212388-bib-0034){ref-type="ref"}. It has also been reported that the gene targeting event resulted in the failure of germline transmission in SD rat ES cells [32](#feb212388-bib-0032){ref-type="ref"}. Previous reports attributed their low gene targeting frequency to ES cells sensitivity to drug screening [27](#feb212388-bib-0027){ref-type="ref"}. However, we were able to use the more strict double selection (*neo* and *tk*) typically used in mouse ES cells, thus excluding most nontargeted ES cells and increasing our overall targeting efficiency. Furthermore, for unknown reasons, cultured rat ES cells often have unstable karyotype and tedious subcloning was used to find clones with normal karyotypes. However, in our study, we were able to obtain gene‐targeted SD and F344 ES cells without tedious subcloning. In our procedure, the addition of A‐83‐01 (the inhibitor of TGF‐β type I receptor ALK5 kinase) in the culture medium could probably have helped maintain rat ES cells relatively free of karyotypes abnormality [3](#feb212388-bib-0003){ref-type="ref"}, [35](#feb212388-bib-0035){ref-type="ref"}.

Compared to previously published rat knockout work in ES cells [27](#feb212388-bib-0027){ref-type="ref"}, [32](#feb212388-bib-0032){ref-type="ref"}, [34](#feb212388-bib-0034){ref-type="ref"}, our gene targeting procedure is optimized in multiple steps, including β2 mouse feeders, positive neomycin (*neo*) and negative FIAU (*tk*) selections, 3i culture medium, DA/SD hybrid recipient blastocysts, and so on. These resulted in higher targeting efficiency and germline transmission efficiency than other procedures. We believe that CRISPR and other gene editing tools can be perfectly combined with homologous recombination‐based gene targeting technology to further improve targeting efficiency.

In conclusion, ACN self‐excision cassette can be successfully used to obtain gene knockout rats and we speculate that the mature gene editing technology established in mouse may be applied to the rat as well as other species, including human.
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